164 related articles for article (PubMed ID: 35712990)
21. Jumping on the Bandwagon: A Review on the Versatile Applications of Gold Nanostructures in Prostate Cancer.
Sarkis M; Ghanem E; Rahme K
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813391
[TBL] [Abstract][Full Text] [Related]
22. Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.
Hendriks RJ; van Oort IM; Schalken JA
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):12-19. PubMed ID: 27922627
[TBL] [Abstract][Full Text] [Related]
23. Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer.
Huang M; Teng Q; Cao F; Huang J; Pang J
Biomater Sci; 2024 Mar; 12(7):1617-1629. PubMed ID: 38379396
[TBL] [Abstract][Full Text] [Related]
24. Serum markers for prostate cancer: a rational approach to the literature.
Steuber T; O'Brien MF; Lilja H
Eur Urol; 2008 Jul; 54(1):31-40. PubMed ID: 18243505
[TBL] [Abstract][Full Text] [Related]
25. Comparison of prostate-specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer.
Sengupta S; Asha Krishnan M; Chattopadhyay S; Chelvam V
Cancer Rep (Hoboken); 2019 Aug; 2(4):e1169. PubMed ID: 32721116
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronic acid and hyaluronidase as possible novel urine biomarkers for the diagnosis of prostate cancer.
Skarmoutsos I; Skarmoutsos A; Katafigiotis I; Tataki E; Giagini A; Adamakis I; Alamanis C; Duvdevani M; Sitaras N; Constantinides C
Med Oncol; 2018 May; 35(7):97. PubMed ID: 29802604
[TBL] [Abstract][Full Text] [Related]
27. Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis.
Agnello L; Vidali M; Giglio RV; Gambino CM; Ciaccio AM; Lo Sasso B; Ciaccio M
Clin Chem Lab Med; 2022 Jul; 60(8):1261-1277. PubMed ID: 35567430
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy.
Roscigno M; Scattoni V; Freschi M; Abdollah F; Maccagnano C; Galosi A; Lacetera V; Montironi R; Muzzonigro G; Deho F; Deiana G; Belussi D; Chinaglia D; Montorsi F; Da Pozzo LF
BJU Int; 2012 May; 109(9):1329-34. PubMed ID: 21895935
[TBL] [Abstract][Full Text] [Related]
29. Imaging cancer cells with nanostructures: Prospects of nanotechnology driven non-invasive cancer diagnosis.
Augustine R; Mamun AA; Hasan A; Salam SA; Chandrasekaran R; Ahmed R; Thakor AS
Adv Colloid Interface Sci; 2021 Aug; 294():102457. PubMed ID: 34144344
[TBL] [Abstract][Full Text] [Related]
30. Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers.
Calatayud DG; Neophytou S; Nicodemou E; Giuffrida SG; Ge H; Pascu SI
Front Chem; 2022; 10():830133. PubMed ID: 35494646
[TBL] [Abstract][Full Text] [Related]
31. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
32. A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Prostate Health Index and 4-Kallikrein Panel Score in Predicting Overall and High-grade Prostate Cancer.
Russo GI; Regis F; Castelli T; Favilla V; Privitera S; Giardina R; Cimino S; Morgia G
Clin Genitourin Cancer; 2017 Aug; 15(4):429-439.e1. PubMed ID: 28111174
[TBL] [Abstract][Full Text] [Related]
33. Development of QDs-based nanosensors for heavy metal detection: A review on transducer principles and in-situ detection.
Wang X; Kong L; Zhou S; Ma C; Lin W; Sun X; Kirsanov D; Legin A; Wan H; Wang P
Talanta; 2022 Mar; 239():122903. PubMed ID: 34857381
[TBL] [Abstract][Full Text] [Related]
34. Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates.
Barani M; Sabir F; Rahdar A; Arshad R; Kyzas GZ
Nanomaterials (Basel); 2020 Aug; 10(9):. PubMed ID: 32872181
[TBL] [Abstract][Full Text] [Related]
35. [Shear wave elastography for guiding prostate puncture and differential diagnosis of prostatic lesions].
Wei J; Yang X; Wei C; Zhang YB
Zhonghua Nan Ke Xue; 2019 Sep; 25(9):792-796. PubMed ID: 32233205
[TBL] [Abstract][Full Text] [Related]
36. [Role of tissue markers on diagnosis, prognosis and monitoring of prostate cancer].
Mora MJ
Arch Esp Urol; 2015 Apr; 68(3):250-66. PubMed ID: 25948798
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of typical and atypical transition zone prostate cancer and its mimics at multiparametric prostate MRI.
Yu J; Fulcher AS; Winks SG; Turner MA; Clayton RD; Brooks M; Li S
Br J Radiol; 2017 May; 90(1073):20160693. PubMed ID: 28256901
[TBL] [Abstract][Full Text] [Related]
38. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy.
Peng F; Su Y; Zhong Y; Fan C; Lee ST; He Y
Acc Chem Res; 2014 Feb; 47(2):612-23. PubMed ID: 24397270
[TBL] [Abstract][Full Text] [Related]
39. Prostate Cancer Predictive Simulation Modelling, Assessing the Risk Technique (PCP-SMART): Introduction and Initial Clinical Efficacy Evaluation Data Presentation of a Simple Novel Mathematical Simulation Modelling Method, Devised to Predict the Outcome of Prostate Biopsy on an Individual Basis.
Spyropoulos E; Kotsiris D; Spyropoulos K; Panagopoulos A; Galanakis I; Mavrikos S
Clin Genitourin Cancer; 2017 Feb; 15(1):129-138.e1. PubMed ID: 27460552
[TBL] [Abstract][Full Text] [Related]
40. Transmembrane and Tetratricopeptide Repeat Containing 4 Is a Novel Diagnostic Marker for Prostate Cancer with High Specificity and Sensitivity.
Makboul R; Abdelkawi IF; Badary DM; Hussein MRA; Rhim JS; Toraih EA; Zerfaoui M; Abd Elmageed ZY
Cells; 2021 Apr; 10(5):. PubMed ID: 33925440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
